PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.215
https://www.valueinhealthjournal.com/article/S1098-3015(12)00280-X/fulltext
Section Title :
Muscular-Skeletal Disorders
Section Order :
985
First Page :
A38
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00280-X&doi=10.1016/j.jval.2012.03.215